Net Loss of Suven Life Sciences reported to Rs 28.04 crore in the quarter ended June 2024 as against net loss of Rs 24.09 crore during the previous quarter ended June 2023. Sales declined 73.42% to Rs 1.01 crore in the quarter ended June 2024 as against Rs 3.80 crore during the previous quarter ended June 2023.
| Particulars | Quarter Ended |
| Jun. 2024 | Jun. 2023 | % Var. |
| Sales | 1.01 | 3.80 | -73 |
| OPM % | -3023.76 | -737.11 | - |
| PBDT | -26.55 | -22.43 | -18 |
| PBT | -28.04 | -24.09 | -16 |
| NP | -28.04 | -24.09 | -16 |